동물 상처 치료 시장 : 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Animal Wound Care Market was valued at USD 1.4 billion in 2024 and is estimated to grow at a CAGR of 6.5% to reach USD 2.6 billion by 2034, driven by a rising global pet population and the growing trend of treating animals as family members. The steady rise in pet ownership is fueling demand for medical products that cater to wound treatment and post-surgical care. Increasing numbers of injuries and surgeries in both livestock and pets are reinforcing the need for effective healing solutions.

Animal owners are now more willing than ever to invest in healthcare solutions that ensure a quicker recovery for their animals, and this behavior is accelerating market demand. The growing use of wound healing gels, sprays, dressings, and tissue adhesives is also supported by the awareness of infection prevention and overall animal health. The surge in veterinary visits and medical procedures for animals further drives the need for advanced wound care products. The overall shift toward comprehensive pet healthcare solutions and the growth of veterinary facilities are also helping in enhancing product adoption across multiple animal care settings.

The surgical wound care products segment generated USD 557.1 million in 2024. The frequency of operations for various medical conditions in animals is increasing, making wound closure and management a key focus area. The availability of more advanced veterinary treatments has made effective post-operative care critical, further supporting the growth of wound care products. Insurance accessibility in developed countries encourages pet owners to opt for advanced medical procedures, which require more sophisticated wound care.

The companion animal segment held a 64.4% share in 2024, driven by the rising global trend of pet humanization, where dogs, cats, and other pets are increasingly integral family members. With more households adopting companion animals, the need for accessible and high-quality veterinary care has grown significantly. The growing pet population directly contributes to chronic conditions, post-surgical recovery needs, and accidental injuries-factors fueling the uptake of wound care solutions tailored to pets.

United States Animal Wound Care Market generated USD 487.6 million in 2024. The country's high pet adoption rate, combined with a well-established veterinary infrastructure and widespread access to specialty animal hospitals, supports strong product adoption. Furthermore, increasing disposable incomes and insurance penetration for pet health services encourage owners to invest in premium wound care options, further driving market growth across the region.

Companies operating in the Global Animal Wound Care Market, such as Neogen Corporation, Sonoma Pharmaceuticals, Virbac, Medtronic, Elanco Animal Health, Sentrx Animal Care, and Vernacare, are strengthening their foothold through innovation in wound healing solutions, expansion of their product portfolios, and global distribution partnerships. Players like Ethicon and 3M invest in R&D to develop next-generation wound dressings. Strategic acquisitions and collaborations across emerging and established regions are helping these firms expand their reach and cater to livestock and companion animal healthcare demands.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing pet ownership and spending
    • 3.2.1.2 Increasing adoption of pet insurance
    • 3.2.1.3 Growing number of veterinary clinics globally
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of advanced wound care products
    • 3.2.2.2 Competition from human wound care products
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Trump administration tariffs
  • 3.5.1 Impact on trade
    • 3.5.1.1 Trade volume disruptions
    • 3.5.1.2 Retaliatory measures
  • 3.5.2 Impact on the industry
    • 3.5.2.1 Supply-side impact
      • 3.5.2.1.1 Price volatility in key materials
      • 3.5.2.1.2 Supply chain restructuring
      • 3.5.2.1.3 Production cost implications
    • 3.5.2.2 Demand-side impact (selling price)
      • 3.5.2.2.1 Price transmission to end markets
      • 3.5.2.2.2 Market share dynamics
      • 3.5.2.2.3 Consumer response patterns
  • 3.5.3 Key companies impacted
  • 3.5.4 Strategic industry responses
    • 3.5.4.1 Supply chain reconfiguration
    • 3.5.4.2 Pricing and product strategies
    • 3.5.4.3 Policy engagement
  • 3.5.5 Outlook and future considerations
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Surgical wound care products
  • 5.2.1 Sutures and staplers
  • 5.2.2 Tissue adhesives
• 5.3 Advanced wound care products
  • 5.3.1 Foam dressings
  • 5.3.2 Hydrocolloid dressings
  • 5.3.3 Film dressings
  • 5.3.4 Hydrogel dressings
  • 5.3.5 Other advanced wound care products
• 5.4 Traditional wound care products
  • 5.4.1 Tapes
  • 5.4.2 Bandages
  • 5.4.3 Dressings
  • 5.4.4 Absorbents
  • 5.4.5 Other traditional wound care products
• 5.5 Therapy devices

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Companion animals
  • 6.2.1 Dogs
  • 6.2.2 Cats
  • 6.2.3 Horses
  • 6.2.4 Other companion animals
• 6.3 Livestock animals
  • 6.3.1 Cattle
  • 6.3.2 Sheep and goats
  • 6.3.3 Swine
  • 6.3.4 Other livestock animals

Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Veterinary hospitals and clinics
• 7.3 Homecare
• 7.4 Academic and research institutes

Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 3M
• 9.2 B. Braun SE
• 9.3 Dechra Pharmaceuticals
• 9.4 Elanco Animal Health
• 9.5 Ethicon (Johnson & Johnson)
• 9.6 Innovacyn
• 9.7 Jorgen Kruuse
• 9.8 KeriCure
• 9.9 Medtronic
• 9.10 Neogen Corporation
• 9.11 Primavet
• 9.12 Sonoma Pharmaceuticals
• 9.13 Sentrx Animal Care
• 9.14 Virbac
• 9.15 Vernacare (Robinson Healthcare)